Cerulean's Core Values include a passionate commitment to improving the lives of patients and building an outstanding company; scientific excellence and innovation focused on important products and absolute integrity in everything we do.
C E R U L E A N    I N    T H E    N E W S

As Cerulean continues to grow and advance our technologies and programs, we are committed to clear and consistent communication to our external audiences. Here we feature current and historic information concerning our technology, our pipeline and our corporate goals and achievements. Please check in often for the most recent press releases and news coverage.

06.23.09:: Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc., a Subsidiary of Arrowhead Research Corporation View Press Release

04.08.09:: Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer View Press Release

01.23.09:: Sandra Glucksmann Named 2009 Mass High Tech Woman to Watch View Press Release

10.24.08 :: Tempo Pharmaceuticals, Inc. Announces Name Change to Cerulean Pharma Inc. View Press Release

 


Company :: Technology :: Careers :: News :: Contact :: Home :: Privacy Policy :: Terms & Conditions of Use

Cerulean Pharma, Inc. 161 First Street Cambridge, MA 02142     p 617 551 9600    f 617 494 1544
Copyright 2008 © Cerulean Pharma, Inc. All rights reserved.